Wilmington, DE, United States of America

James Martin Delaney

This inventor holds 2 USPTO granted patents. Top assignee: Ciba Specialty Chemicals Corporation. Active years: 1999-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Martin Delaney. Retrieved from https://idiyas.com/inventor/james-martin-delaney

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1999-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Journey of James Martin Delaney

Introduction: James Martin Delaney is a renowned inventor based in Wilmington, Delaware. His passion for innovation has led to groundbreaking developments in various fields.

Latest Patents: James Martin Delaney holds several patents in the areas of renewable energy, sustainable technology, and medical devices, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Delaney has worked with top research institutions and companies to bring his inventions to life. His commitment to pushing the boundaries of technology has earned him recognition in the industry.

Collaborations: Throughout his career, James Martin Delaney has collaborated with leading universities, innovative companies, and talented individuals to drive forward progress in innovation. His collaborative spirit has been instrumental in the success of many projects.

Conclusion: James Martin Delaney's relentless pursuit of innovation and collaboration has cemented his legacy as a visionary inventor. His contributions to various fields continue to inspire the next generation of innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…